SAFETY AND TOLERABILITY OF FENTANYL SUBLINGUAL SPRAY DURING THE TITRATION PHASE OF TWO PHASE 3 CLINICAL TRIALS: A POOLED ANALYSIS

被引:0
|
作者
Rauck, Richard [1 ]
Stearns, Lisa [2 ]
Forman, Nicole [3 ]
Parikh, Neha [3 ]
机构
[1] Clin Res Ctr, Winston Salem, NC USA
[2] Ctr Pain & Support Care, Scottsdale, AZ USA
[3] Insys Therapeut, Chandler, AZ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
62
引用
收藏
页码:E225 / E225
页数:1
相关论文
共 50 条
  • [31] Trabectedin phase II clinical trials: Pooled analysis of safety in patients with solid tumors
    Cioffi, A.
    LeCesne, A.
    Blay, J.
    Delaloge, S.
    Yovine, A.
    Maki, R.
    Nieto, A.
    Jiao, J. J.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] SECUKINUMAB SAFETY AND TOLERABILITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM A POOLED SAFETY ANALYSIS OF SEVEN INTERNATIONAL PHASE 3 TRIALS
    Soriano, Enrique
    Gottlieb, Alice
    McInnes, Ian B.
    Mease, Philip
    Mpofu, Shephard
    Widmer, Albert
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 140 - 140
  • [33] Safety and Tolerability of Opicapone in Patients with Parkinson's Disease and Motor Fluctuations: Pooled Analysis of Two Phase 3 Studies
    Kremens, D.
    Poewe, W.
    Rascol, O.
    Olson, K.
    Farahmand, K.
    Siegert, S.
    McMicken, C.
    Rocha, J. F.
    Soares-da-Silva, P.
    Liang, G. S.
    MOVEMENT DISORDERS, 2019, 34 : S8 - S8
  • [34] Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials
    Fahmy, Ahmad M.
    Harthan, Jennifer S.
    Evans, David G.
    Greiner, Jack V.
    Tauber, Joseph
    Sheppard, John D.
    Krosser, Sonja
    Vittitow, Jason L.
    FRONTIERS IN OPHTHALMOLOGY, 2024, 4
  • [35] Efficacy and safety of satralizumab for relapse prevention in neuromyelitis optica spectrum disorder: a pooled analysis from two Phase 3 clinical trials
    Yamamura, Takashi
    de Seze, Jerome
    Weinshenker, Brian G.
    Terada, Yusuke
    Kawata, Yuichi
    Gianella-Borradori, Athos
    von Budingen, Christian
    Klingelschmitt, Gaelle
    Traboulsee, Anthony
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP100 - NP101
  • [36] Efficacy and safety of satralizumab for relapse prevention in neuromyelitis optica spectrum disorder: a pooled analysis from two phase 3 clinical trials
    de Seze, J.
    Weinshenker, B. G.
    Terada, Y.
    Kawata, Y.
    Gianella-Borradori, A.
    von Budingen, C.
    Klingelschmitt, G.
    Traboulsee, A.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 904 - 905
  • [37] Long-term safety and tolerability of apremilast in patients with psoriasis: pooled safety analysis of two phase randomized controlled trials (ESTEEM 1 and 2)
    Reich, K.
    Papp, K.
    Gordon, K.
    Griffiths, C.
    Chimenti, S.
    Lopez-Estebaranz, J. L.
    Gottlieb, A.
    Shah, K.
    Hu, C. C.
    Stevens, R.
    Day, R.
    Paul, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E145 - E146
  • [38] Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials
    Kane, John M.
    Durgam, Suresh
    Satlin, Andrew
    Vanover, Kimberly E.
    Chen, Richard
    Davis, Robert
    Mates, Sharon
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 244 - 250
  • [39] Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: pooled analysis of phase I-III clinical trials
    Yabe, D.
    Yasui, A.
    Ji, L.
    Lee, M. -K.
    Ma, R.
    Chang, T. -J.
    Okamura, T.
    Zeller, C.
    Kaspers, S.
    Lee, J.
    Kohler, S.
    Seino, Y.
    DIABETOLOGIA, 2018, 61 : S307 - S307
  • [40] Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials
    Yabe, Daisuke
    Yasui, Atsutaka
    Ji, Linong
    Lee, Moon-Kyu
    Ma, Ronald Ching Wan
    Chang, Tien-Jyun
    Okamura, Tomoo
    Zeller, Cordula
    Kaspers, Stefan
    Lee, Jisoo
    Kohler, Sven
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 418 - 428